电邮这篇文章 Hyperfiltration is an early sign of evolving chronic renal disease in males with metabolic syndrome
- 作者: Novikova M.S.1, Shilov E.M.1, Borisov V.V.1, Novikova MS2, Shilov EM2, Borisov VV2
-
隶属关系:
- Department of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical Academy
- 期: 卷 82, 编号 4 (2010)
- 页面: 52-56
- 栏目: Editorial
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.04.2010
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30596
- ID: 30596
如何引用文章
全文:
详细
Aim. To study the time course of changes in glomerular filtration rate (GFR) in different age groups of males with metabolic syndrome (MS).
Subjects and methods. Eighty-six male patients with MS whose age 35 to 69 years (mean age 53.6 years) were examined. The patients were divided into 3 age groups: 1) 30-50 years (mean age 43.5 years; n = 30); 2) 50-60 years (mean age 54.9 years; n = 36); 3) 60-70 (mean age 66 years; n = 20).
The study included only MS patients with stages I-III chronic renal disease (CRD) (according to the NKF K/DOQI classification, 2002). GFR was determined by the Cockroft-Gault formula corrected and uncorrected for a standard body surface area (GFRst, GFRc-g).
The obtained values of GFRst and GFRc-g were compared with the population-based standards determined for each formula. The authors identified an increased GFRst (> 110 ml/min/1.73 m2), a normal GFRst (60-110 ml/min/1.73 m2), and a decreased GFRst (< 60 ml/min/1.73 m2), as well as an increased GFRc-g (> 120 ml/min), a normal GFRc-g (80-120 ml/min), and a decreased GFRc-g (< 80 ml/min). GFRst < 60 ml/min/1.73 m2) was defined as CRD.
Results. Each age group was found to have deviations of GFR from the normal values towards both its increase and decrease. The young age group showed a larger number of patients with increased GFR and a smaller number of patients with decreased GFR than did the old age group. This trend was seen for both GFRst and GFRc-g, but in the latter case, the spread of hyperfiltration was higher in the age group of 30-50 years and in the total group of patients.
Conclusion. In the first age group, a predominance of hemofiltration precedes the development of CRD in the third age group and may reflect the trend of MS-induced renal lesion.
Subjects and methods. Eighty-six male patients with MS whose age 35 to 69 years (mean age 53.6 years) were examined. The patients were divided into 3 age groups: 1) 30-50 years (mean age 43.5 years; n = 30); 2) 50-60 years (mean age 54.9 years; n = 36); 3) 60-70 (mean age 66 years; n = 20).
The study included only MS patients with stages I-III chronic renal disease (CRD) (according to the NKF K/DOQI classification, 2002). GFR was determined by the Cockroft-Gault formula corrected and uncorrected for a standard body surface area (GFRst, GFRc-g).
The obtained values of GFRst and GFRc-g were compared with the population-based standards determined for each formula. The authors identified an increased GFRst (> 110 ml/min/1.73 m2), a normal GFRst (60-110 ml/min/1.73 m2), and a decreased GFRst (< 60 ml/min/1.73 m2), as well as an increased GFRc-g (> 120 ml/min), a normal GFRc-g (80-120 ml/min), and a decreased GFRc-g (< 80 ml/min). GFRst < 60 ml/min/1.73 m2) was defined as CRD.
Results. Each age group was found to have deviations of GFR from the normal values towards both its increase and decrease. The young age group showed a larger number of patients with increased GFR and a smaller number of patients with decreased GFR than did the old age group. This trend was seen for both GFRst and GFRc-g, but in the latter case, the spread of hyperfiltration was higher in the age group of 30-50 years and in the total group of patients.
Conclusion. In the first age group, a predominance of hemofiltration precedes the development of CRD in the third age group and may reflect the trend of MS-induced renal lesion.
作者简介
Mariya Novikova
Email: citrus7474@mail.ru
Evgeniy Shilov
Email: emshilov@stream.ru
Vladimir Borisov
Email: vvb56@yandex.ru
M Novikova
Department of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical AcademyDepartment of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical Academy
E Shilov
Department of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical AcademyDepartment of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical Academy
V Borisov
Department of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical AcademyDepartment of Nephrology and Hemodialysis, I. M. Sechenov Moscow Medical Academy
参考
- Чазова И. Е., Мычка В. Б. Метаболический синдром, сахарный диабет 2-го типа и артериальная гипертензия. Сердце 2003; 3 (9): 12-20.
- Ihab M., Wahba A., Mak R. H. Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2007; 2: 550-562.
- Zimmet P., Show J. Preventing type 2 diabetes and the dysmetabolic syndrome in the real word. Diabet. Med. 2003; 20 (9): 693-700.
- Ford E. S., Giles W. H., Dietz W. H. et al. Increasing prevalence of the metabolic syndrome among U. S. adults. Diabet. Care 2004; 27: 2444-2449.
- Hanley A. J., Wagenknecht L. E. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003; 52: 2740-2747.
- Lesley A. S., Coresh J., Greene T., Levey A. S. Assessing kidney function - measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006; 354: 2473-2483.
- Фомин В. В. Хроническая болезнь почек. В кн.: Шилов Е. М. (ред.). Нефрология: Учеб. пособие для послевузовского образования. М.: ГЭОТАР-Медиа; 2007. 599-600.
- Coresh J., Astor B. C., Greene T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003; 41: 1-12.
- Мухин Н. А., Моисеев В. С. Кардиоренальные отношения и риск сердечно-сосудистых осложнений. Вестн. РАМН 2003; 11: 50-55.
- Мухин Н. А., Моисеев В. С., Кобалава Ж. Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер. арх. 2004; 6: 39-47.
- Tuttle K. R. Renal manifestations of the metabolic syndrome. Nephrol. Dial. Transplant. 2005; 20 (5): 861-864.
- Schelling J. R., Sedor J. R. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J. Am. Soc. Nephrol. 2004; 15: 2773-2774.
- Мухин Н. А., Фомин В. В. Образ жизни и хронические заболевания почек. В кн.: Шилов Е. М. (ред.). Нефрология: Учеб. пособие для послевузовского образования. М.: ГЭОТАР-Медиа; 2007. 613-615.
- Tomaszewski M., Charchar F. J., Maric C. et al. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int. 2007; 71: 816-821.
- Tantravahi J. R., Srinivas T. R., Johnson R. J. Hyperfiltration: a sign of poor things to come in individuals with metabolic syndrome. Nat. Clin. Pract. Nephrol. 2007; 3: 474-475.
- Delanaye P., Radermecker R. P., Rorive M. et al. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol. Dial. Transpant. 2005; 20 (10): 2024-2028.
- Bachorzewska-Gajewska H., Malyszko J., Malyszko J. S. et al. Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal? Nephrol. Dial. Transplant. 2006; 21 (6): 1736-1738.
- Wase E., Isoaho R., Mattila K. et al. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J. Intern. Med. 2004; 256: 70-78.
- Fliser D., Franek E., Joest M. et al. Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int. 1997; 51: 1196-1204.
- Wetzels J. F., Kiemeney L. A., Swinkels D. W. et al. Age- and gender-specific reference values of estimated GFR I Caucasians: The Nijmegen Biomedical Study. Kidney International advance online publication 2007.
- Chagnac A., Weinstein T., Korzets A. et al. Glomerular hemodynamics in severe obesity. Am. J. Physiol. 2000; 278: F817- F822.
- Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 2004; 140: 167-174.
- Sowers J. R. Metabolic risk factors and renal disease. Kidney Int. 2007; 71: 719-720.
- Краснова Е. А., Моисеев С. В., Фомин В. В. Нефрологические аспекты проблемы ожирения. Клин. мед. 2005; 4: 9- 14.
- Hall J. E. Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 2002; 324: 127-137.
- Кутырина И. М., Рогов В. А., Шестакова М. В., Зверев К. В. Гиперфильтрация как фактор прогрессирования хронических заболеваний почек. Тер. арх. 1992; 6: 10-15.
- Chagnac A., Weinstein T., Herman M. et al. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol. 2003; 14: 1480-1486.
补充文件
